Safety concerns raised for neuroblastoma candidate drug

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Then researchers identified safety concerns with the experimental drug that have implications for current clinical trials in adults.

Read more: https://medicalxpress.com/news/2021-11-safety-neuroblastoma-candidate-drug.html